When To Hold ’Em: Post-IPO, VCs Keep Their Cards
This article was originally published in Start Up
Executive Summary
As biopharma IPOs show real signs of life, venture backers could reach exits they’ve been waiting on for years. Only a handful of investors with significant stakes have participated in multiple IPOs since the start of 2012.